Arcutis Biotherapeutics, Inc. (ARQT)
24.79
-0.29
(-1.16%)
USD |
NASDAQ |
Aug 24, 16:00
24.79
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price : 24.79 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 25.49 | 25.67 | 24.73 | 25.08 | 2.159M |
| Aug 20, 2026 | 26.50 | 26.56 | 24.53 | 25.35 | 3.289M |
| Aug 19, 2026 | 27.00 | 27.19 | 26.37 | 26.46 | 1.025M |
| Aug 18, 2026 | 25.51 | 26.71 | 25.49 | 26.54 | 1.972M |
| Aug 17, 2026 | 26.20 | 26.34 | 25.51 | 25.61 | 1.710M |
| Aug 14, 2026 | 25.39 | 26.24 | 25.28 | 26.19 | 1.110M |
| Aug 13, 2026 | 26.57 | 26.65 | 25.76 | 25.83 | 1.586M |
| Aug 12, 2026 | 26.62 | 26.62 | 25.92 | 26.28 | 1.184M |
| Aug 11, 2026 | 26.24 | 26.82 | 25.82 | 26.23 | 1.050M |
| Aug 10, 2026 | 24.93 | 25.95 | 24.76 | 25.92 | 2.095M |
| Aug 07, 2026 | 26.65 | 26.88 | 25.26 | 25.29 | 2.449M |
| Aug 06, 2026 | 29.21 | 29.24 | 26.23 | 26.43 | 3.264M |
| Aug 05, 2026 | 26.07 | 27.11 | 26.06 | 27.10 | 2.449M |
| Aug 04, 2026 | 26.07 | 26.40 | 25.84 | 26.03 | 1.939M |
| Aug 03, 2026 | 26.67 | 26.86 | 25.63 | 25.94 | 1.571M |
| Jul 31, 2026 | 27.77 | 27.96 | 26.32 | 26.86 | 1.549M |
| Jul 30, 2026 | 28.01 | 28.14 | 27.33 | 27.99 | 1.267M |
| Jul 29, 2026 | 28.18 | 28.52 | 27.72 | 27.86 | 977252.0 |
| Jul 28, 2026 | 28.09 | 28.53 | 27.51 | 28.42 | 1.066M |
| Jul 27, 2026 | 27.62 | 28.60 | 27.54 | 27.84 | 1.199M |
| Jul 24, 2026 | 27.50 | 27.69 | 26.78 | 27.35 | 819356.0 |
| Jul 23, 2026 | 27.30 | 27.93 | 26.98 | 27.33 | 1.031M |
| Jul 22, 2026 | 28.05 | 28.46 | 27.69 | 27.90 | 802453.0 |
| Jul 21, 2026 | 27.53 | 28.50 | 27.52 | 28.26 | 1.370M |
| Jul 20, 2026 | 28.54 | 28.98 | 27.50 | 27.53 | 1.254M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 29.63 |
| Insmed, Inc. | 124.03 |
| Emergent BioSolutions, Inc. | 5.17 |
| Exelixis, Inc. | 54.57 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
Price Related Metrics
| PE Ratio | 119.70 |
| PS Ratio | 7.130 |
| Price to Book Value | 14.11 |
| Price to Free Cash Flow | 84.50 |
| Earnings Yield | 0.84% |
| Market Cap | 3.113B |
| Operating PE Ratio | 96.58 |
| Normalized PE Ratio | 119.47 |